QUADRACEL
Google image searchProduct monograph
Active ingredients
diphtheria toxoid, 15 LF/0.5 ML
tetanus toxoid, 5 LF/0.5 ML
pertussis toxoid, 20 MCG/0.5 ML
filamentous haemagglutinin, 20 MCG/0.5 ML
pertactin, 3 MCG/0.5 ML
fimbriae types 2 and 3 (fim), 5 MCG/0.5 ML
inactivated poliomyelitis vaccine (v.c.o.) type 1 mahoney, 29 UNIT/0.5 ML
inactivated poliomyelitis vaccine (v.c.o.) type 2 mef1, 7 UNIT/0.5 ML
inactivated poliomyelitis vaccine (v.c.o.) type 3 saukett, 26 UNIT/0.5 ML
DIN: 02534789
Dosage form(s): SUSPENSION
Route(s) of administration: INTRAMUSCULAR
Schedule: Schedule D
Company: SANOFI PASTEUR LIMITED
Date: 06-MAY-2024
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07C — BACTERIAL AND VIRAL VACCINES, COMBINED (ATC, ATC/DDD)
- J07CA — Bacterial and viral vaccines, combined (ATC, ATC/DDD)
- J07CA02 — DIPHTHERIA-PERTUSSIS-POLIOMYELITIS-TETANUS (ATC/DDD)
External Links for Quadracel
Search on Google
- Quadracel side effects
- Quadracel dosage
- diphtheria toxoid side effects
- diphtheria toxoid dosage
- tetanus toxoid side effects
- tetanus toxoid dosage
- pertussis toxoid side effects
- pertussis toxoid dosage
- filamentous haemagglutinin side effects
- filamentous haemagglutinin dosage
- pertactin side effects
- pertactin dosage
- fimbriae types 2 and 3 side effects
- fimbriae types 2 and 3 dosage
- inactivated poliomyelitis vaccine side effects
- inactivated poliomyelitis vaccine dosage
- inactivated poliomyelitis vaccine side effects
- inactivated poliomyelitis vaccine dosage
- inactivated poliomyelitis vaccine side effects
- inactivated poliomyelitis vaccine dosage
